MAR 24, 2016 11:23 AM PDT

New Gene Player Identified in Breast Cancer

WRITTEN BY: Xuan Pham
GT198 mutations could lead to new target for breast cancer diagnosis and therapy

There’s a new gene player in breast cancer, and it’s called GT198. Already known to be mutated in early onset breast and ovarian cancer, researchers now show that mutation of GT198 in breast progenitor cells can induce tumor formation. This genetic player represents potentially new ways to diagnose and target breast cancer.

Dr. Nahid Mivechi, Dr. Nita Maihle, Dr. Lan KoThe gene GT198, also known as PSMC3IP, encodes a protein that functions in meiotic recombination and DNA repair. More pertinent to breast cancer, GT198 protein products activate other genes in the presence of the hormone estrogen. Mutations in GT198 cause the gene to function even in the absence of estrogen signals. "Regardless of how much hormone you have, it's out-of-control growth," said Lan Ko, cancer biologist at the Medical College of Georgia (MCG) at Augusta University, and senior study author.
 
In a sampling of 249 cases of breast cancer tissues in pre- and postmenopausal women, the team found GT198 protein in breast stromal tissues but not in the 11 healthy tissue controls. "This gene mutation can be in both the blood and the tumor tissue of patients, and in the tissue, it's in high percentages," said Ko. "We believe that once this gene is mutated, it induces the tumor to grow."
 
Stromal tissues is made up of a collection of cells, including fat cells and connective tissues, that provide padding and structural support for the ductal system in the breast. Researchers have previously observed changes in the stroma for breast cancer patients, but they did not know the genetic cause. That the GT198 protein was found in stromal tissue provided the ‘smoking gun’ researchers were hoping to find.
 
"This puts it together," Ko said, referring to the mutation of GT198 in the breast precursor cells that then make up the various components of the stroma. It’s thought that the mutated form of GT198 stimulates blood vessel growth and fat production – activities that create a more favorable environment for breast cancer to proliferate.
 

"It's a new target in cancer. It's very exciting," said Nita Maihle, MCG cancer biologist and a study co-author. "This tells you that all the different types of stromal cells in breast tissue are affected by the GT198 mutation because they all come from a common progenitor cell."
 
A major consequence of this finding is the potential for GT198 to be a new target in breast cancer therapy. A drug that directly blocks GT198 protein in progenitor cells would have the capacity to be very effective, as it would nip cancer where it begins. "We think the way to treat breast cancer is to target the progenitor cells. We want to kill these cells that are feeding the tumor rather than just killing the tumor cells, which is less effective,” said Ko.
 
Another consequence of this discovery is the potential for GT198 to be a new biomarker in ductal breast cancer. Detecting stromal cells that are positive for the GT198 mutations and expression the protein could enhance diagnosis of cancer in the early stages. 

Additional source: EurekAlert!
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
AUG 26, 2020
Cancer
NAP-6: A Potential Candidate for the Treatment of Breast Cancer
AUG 26, 2020
NAP-6: A Potential Candidate for the Treatment of Breast Cancer
The body is an amazing and complex system of pathways, all working together in harmony. However, cancer can quickly disr ...
SEP 04, 2020
Cancer
Attacking Cancer's Metabolism: A New Take on Fermented Wheat Germ Extract
SEP 04, 2020
Attacking Cancer's Metabolism: A New Take on Fermented Wheat Germ Extract
One of the hallmarks of evolution is the oxidative phosphorylation metabolic system. Not only does it produce energy in ...
SEP 17, 2020
Cardiology
Can Grape Polyphenol Extracts prevent Cardiotoxicity?
SEP 17, 2020
Can Grape Polyphenol Extracts prevent Cardiotoxicity?
One of the biggest issues with chemotherapy treatments is their inherent toxicities. Most chemotherapy drugs are toxic t ...
SEP 14, 2020
Genetics & Genomics
Why Defects in One Gene Can Lead to Cancer in Kids
SEP 14, 2020
Why Defects in One Gene Can Lead to Cancer in Kids
While they may occur in adults, a rare, aggressive type of brain cancer called atypical teratoid rhabdoid tumors tend to ...
OCT 05, 2020
Cancer
Fighting mitochondrial terminal exhaustion
OCT 05, 2020
Fighting mitochondrial terminal exhaustion
New findings reported in Nature Immunology highlight how the tumor microenvironment attacks the mitochondria of T l ...
OCT 12, 2020
Cancer
Targeting Energy Production in Cells to Fight Leukemia
OCT 12, 2020
Targeting Energy Production in Cells to Fight Leukemia
Much like how a car needs gasoline to run, cells also need a fuel source. Most human cells in the body use oxidative pho ...
Loading Comments...